Skip to content

Troponin T in Chronic Obstructive Pulmonary Disease (COPD) Patients After Physical Exercise

COPD, Physical Exercise and Troponin T

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02721693
Enrollment
20
Registered
2016-03-29
Start date
2016-04-30
Completion date
2016-10-31
Last updated
2016-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD, Myocardial Diseases

Keywords

Troponin, Exercise

Brief summary

The primary purpose of the study is to investigate if physical exercise is associated with myocardial damage, expressed by elevated troponin T, in patients with COPD.

Detailed description

Patients with COPD will perform a cardiopulmonary exercise test (CPET) on treadmill until exhaustion, 8-12 minutes. Venous blood will be drawn before exercise test and 15 minutes, 3 hours and 24 hours after test for analysis of high sensitive Cardiac troponin T (hs-cTnT). The investigators will also measure arterial bloodgas, oxygen uptake, carbon dioxide consumption, ventilation, blood pressure, ECG, heart rate and ask for dyspnea-score.

Interventions

Patients are subjected to an incremental exercise test to exhaustion on a treadmill

Sponsors

LHL Helse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* COPD * GOLD 2-4 * BODE-index ≥ 2 * Referred by physician to a CPET

Exclusion criteria

* Other serious pulmonary diseases (e.g. cancer, sarcoidosis, restrictive pulmonary diseases) * Chronic heart disease with unstable angina or myocardial infarction ≤ 3 months prior to inclusion * Percutaneous coronary intervention (PCI) * Hypertension that is not controlled

Design outcomes

Primary

MeasureTime frame
Troponin T concentration 3 h3 h

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026